VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection
Oncolytic viruses designed to attack malignant cells can in addition infect and destroy tumor vascular endothelial cells. We show here that this expanded tropism of oncolytic vaccinia virus to the endothelial compartment is a consequence of VEGF-mediated suppression of the intrinsic antiviral respon...
Gespeichert in:
| Veröffentlicht in: | Cancer cell 2015-08, Vol.28 (2), p.210-224 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 224 |
|---|---|
| container_issue | 2 |
| container_start_page | 210 |
| container_title | Cancer cell |
| container_volume | 28 |
| creator | Arulanandam, Rozanne Batenchuk, Cory Angarita, Fernando A. Ottolino-Perry, Kathryn Cousineau, Sophie Mottashed, Amelia Burgess, Emma Falls, Theresa J. De Silva, Naomi Tsang, Jovian Howe, Grant A. Bourgeois-Daigneault, Marie-Claude Conrad, David P. Daneshmand, Manijeh Breitbach, Caroline J. Kirn, David H. Raptis, Leda Sad, Subash Atkins, Harold Huh, Michael S. Diallo, Jean-Simon Lichty, Brian D. Ilkow, Carolina S. Le Boeuf, Fabrice Addison, Christina L. McCart, J. Andrea Bell, John C. |
| description | Oncolytic viruses designed to attack malignant cells can in addition infect and destroy tumor vascular endothelial cells. We show here that this expanded tropism of oncolytic vaccinia virus to the endothelial compartment is a consequence of VEGF-mediated suppression of the intrinsic antiviral response. VEGF/VEGFR2 signaling through Erk1/2 and Stat3 leads to upregulation, nuclear localization, and activation of the transcription repressor PRD1-BF1/Blimp1. PRD1-BF1 does not contribute to the mitogenic effects of VEGF, but directly represses genes involved in type I interferon (IFN)-mediated antiviral signaling. In vivo suppression of VEGF signaling diminishes PRD1-BF1/Blimp1 expression in tumor vasculature and inhibits intravenously administered oncolytic vaccinia delivery to and consequent spread within the tumor.
[Display omitted]
•VEGF/VEGFR2 signaling sensitizes endothelial cells to oncolytic virus infection•PRD1-BF1 mediates immune suppression in endothelial cells downstream of VEGF•PRD1-BF1 is induced in remodelling vessels by chronic or transient VEGF stimulation•Infection of tumor vasculature orchestrated by PRD1-BF1 is critical for OV delivery
Arulanandam et al. show that VEGFR2 signaling in remodelling vessels induces the transcription repressor PRD1-BF1/Blimp1, which represses the expression of genes involved in type I interferon-mediated antiviral signaling, thus allowing oncolytic virus to infect tumor vasculatures to further spread within tumors. |
| doi_str_mv | 10.1016/j.ccell.2015.06.009 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1709165117</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1535610815002196</els_id><sourcerecordid>1709165117</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4889-5ed459e44732fa4d51ca641b9088de9fc9f461bf2a8db0262f66662b6245613c3</originalsourceid><addsrcrecordid>eNqNkUFv1DAQhSNERUvhFyAhH7kk9Ti24xw40LJbKrVqBWWvlmNPJK-SeLETRPn1eLuFI6ovtuT33mjeVxTvgFZAQZ5tK2txGCpGQVRUVpS2L4oTUI0qa6nky_wWtSglUHVcvE5pS7MLmvZVccwkA8YEPSnCZnW5Lm_QeTOjI1eTW-zsw0RCT-6-fobyfA1n54Mfd0BWv3YRU9r_fsMp-dn_xkTulzFEsjHJLoOZl4hkDuR2smF4mL0lGx-XlHN7fMx9Uxz1Zkj49uk-Lb6vV_cXX8rr28uri0_XpeVKtaVAx0WLnDc16w13AqyRHLqWKuWw7W3bcwldz4xyHc3r9DIf1knGhYTa1qfFh0PuLoYfC6ZZjz7t6zIThiVpaGgLUgA0z5HyWtSNFFlaH6Q2hpQi9noX_Wjigwaq91D0Vj9C0XsomkqdoWTX-6cBSzei--f5SyELPh4EmBv56THqZD1ONlOJuTbtgv_vgD-Zvp0L</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1704353765</pqid></control><display><type>article</type><title>VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection</title><source>MEDLINE</source><source>Cell Press Free Archives</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Arulanandam, Rozanne ; Batenchuk, Cory ; Angarita, Fernando A. ; Ottolino-Perry, Kathryn ; Cousineau, Sophie ; Mottashed, Amelia ; Burgess, Emma ; Falls, Theresa J. ; De Silva, Naomi ; Tsang, Jovian ; Howe, Grant A. ; Bourgeois-Daigneault, Marie-Claude ; Conrad, David P. ; Daneshmand, Manijeh ; Breitbach, Caroline J. ; Kirn, David H. ; Raptis, Leda ; Sad, Subash ; Atkins, Harold ; Huh, Michael S. ; Diallo, Jean-Simon ; Lichty, Brian D. ; Ilkow, Carolina S. ; Le Boeuf, Fabrice ; Addison, Christina L. ; McCart, J. Andrea ; Bell, John C.</creator><creatorcontrib>Arulanandam, Rozanne ; Batenchuk, Cory ; Angarita, Fernando A. ; Ottolino-Perry, Kathryn ; Cousineau, Sophie ; Mottashed, Amelia ; Burgess, Emma ; Falls, Theresa J. ; De Silva, Naomi ; Tsang, Jovian ; Howe, Grant A. ; Bourgeois-Daigneault, Marie-Claude ; Conrad, David P. ; Daneshmand, Manijeh ; Breitbach, Caroline J. ; Kirn, David H. ; Raptis, Leda ; Sad, Subash ; Atkins, Harold ; Huh, Michael S. ; Diallo, Jean-Simon ; Lichty, Brian D. ; Ilkow, Carolina S. ; Le Boeuf, Fabrice ; Addison, Christina L. ; McCart, J. Andrea ; Bell, John C.</creatorcontrib><description>Oncolytic viruses designed to attack malignant cells can in addition infect and destroy tumor vascular endothelial cells. We show here that this expanded tropism of oncolytic vaccinia virus to the endothelial compartment is a consequence of VEGF-mediated suppression of the intrinsic antiviral response. VEGF/VEGFR2 signaling through Erk1/2 and Stat3 leads to upregulation, nuclear localization, and activation of the transcription repressor PRD1-BF1/Blimp1. PRD1-BF1 does not contribute to the mitogenic effects of VEGF, but directly represses genes involved in type I interferon (IFN)-mediated antiviral signaling. In vivo suppression of VEGF signaling diminishes PRD1-BF1/Blimp1 expression in tumor vasculature and inhibits intravenously administered oncolytic vaccinia delivery to and consequent spread within the tumor.
[Display omitted]
•VEGF/VEGFR2 signaling sensitizes endothelial cells to oncolytic virus infection•PRD1-BF1 mediates immune suppression in endothelial cells downstream of VEGF•PRD1-BF1 is induced in remodelling vessels by chronic or transient VEGF stimulation•Infection of tumor vasculature orchestrated by PRD1-BF1 is critical for OV delivery
Arulanandam et al. show that VEGFR2 signaling in remodelling vessels induces the transcription repressor PRD1-BF1/Blimp1, which represses the expression of genes involved in type I interferon-mediated antiviral signaling, thus allowing oncolytic virus to infect tumor vasculatures to further spread within tumors.</description><identifier>ISSN: 1535-6108</identifier><identifier>EISSN: 1878-3686</identifier><identifier>DOI: 10.1016/j.ccell.2015.06.009</identifier><identifier>PMID: 26212250</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Cell Line ; Cell Line, Tumor ; Cells, Cultured ; Gene Expression - drug effects ; Gene Expression Profiling ; Host-Pathogen Interactions ; Human Umbilical Vein Endothelial Cells - drug effects ; Human Umbilical Vein Endothelial Cells - metabolism ; Human Umbilical Vein Endothelial Cells - virology ; Humans ; Mice, Inbred C57BL ; Microscopy, Fluorescence ; Neoplasms - blood supply ; Neoplasms - therapy ; Neoplasms - virology ; Neovascularization, Pathologic - genetics ; Neovascularization, Pathologic - metabolism ; Neovascularization, Pathologic - virology ; Oncolytic Viruses - physiology ; Positive Regulatory Domain I-Binding Factor 1 ; Receptors, Vascular Endothelial Growth Factor - genetics ; Receptors, Vascular Endothelial Growth Factor - metabolism ; Repressor Proteins - genetics ; Repressor Proteins - metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; RNA Interference ; Transcription Factors - genetics ; Transcription Factors - metabolism ; Transcriptional Activation - drug effects ; Vaccinia virus ; Vaccinia virus - physiology ; Vascular Endothelial Growth Factor A - pharmacology</subject><ispartof>Cancer cell, 2015-08, Vol.28 (2), p.210-224</ispartof><rights>2015 Elsevier Inc.</rights><rights>Copyright © 2015 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4889-5ed459e44732fa4d51ca641b9088de9fc9f461bf2a8db0262f66662b6245613c3</citedby><cites>FETCH-LOGICAL-c4889-5ed459e44732fa4d51ca641b9088de9fc9f461bf2a8db0262f66662b6245613c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1535610815002196$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26212250$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arulanandam, Rozanne</creatorcontrib><creatorcontrib>Batenchuk, Cory</creatorcontrib><creatorcontrib>Angarita, Fernando A.</creatorcontrib><creatorcontrib>Ottolino-Perry, Kathryn</creatorcontrib><creatorcontrib>Cousineau, Sophie</creatorcontrib><creatorcontrib>Mottashed, Amelia</creatorcontrib><creatorcontrib>Burgess, Emma</creatorcontrib><creatorcontrib>Falls, Theresa J.</creatorcontrib><creatorcontrib>De Silva, Naomi</creatorcontrib><creatorcontrib>Tsang, Jovian</creatorcontrib><creatorcontrib>Howe, Grant A.</creatorcontrib><creatorcontrib>Bourgeois-Daigneault, Marie-Claude</creatorcontrib><creatorcontrib>Conrad, David P.</creatorcontrib><creatorcontrib>Daneshmand, Manijeh</creatorcontrib><creatorcontrib>Breitbach, Caroline J.</creatorcontrib><creatorcontrib>Kirn, David H.</creatorcontrib><creatorcontrib>Raptis, Leda</creatorcontrib><creatorcontrib>Sad, Subash</creatorcontrib><creatorcontrib>Atkins, Harold</creatorcontrib><creatorcontrib>Huh, Michael S.</creatorcontrib><creatorcontrib>Diallo, Jean-Simon</creatorcontrib><creatorcontrib>Lichty, Brian D.</creatorcontrib><creatorcontrib>Ilkow, Carolina S.</creatorcontrib><creatorcontrib>Le Boeuf, Fabrice</creatorcontrib><creatorcontrib>Addison, Christina L.</creatorcontrib><creatorcontrib>McCart, J. Andrea</creatorcontrib><creatorcontrib>Bell, John C.</creatorcontrib><title>VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection</title><title>Cancer cell</title><addtitle>Cancer Cell</addtitle><description>Oncolytic viruses designed to attack malignant cells can in addition infect and destroy tumor vascular endothelial cells. We show here that this expanded tropism of oncolytic vaccinia virus to the endothelial compartment is a consequence of VEGF-mediated suppression of the intrinsic antiviral response. VEGF/VEGFR2 signaling through Erk1/2 and Stat3 leads to upregulation, nuclear localization, and activation of the transcription repressor PRD1-BF1/Blimp1. PRD1-BF1 does not contribute to the mitogenic effects of VEGF, but directly represses genes involved in type I interferon (IFN)-mediated antiviral signaling. In vivo suppression of VEGF signaling diminishes PRD1-BF1/Blimp1 expression in tumor vasculature and inhibits intravenously administered oncolytic vaccinia delivery to and consequent spread within the tumor.
[Display omitted]
•VEGF/VEGFR2 signaling sensitizes endothelial cells to oncolytic virus infection•PRD1-BF1 mediates immune suppression in endothelial cells downstream of VEGF•PRD1-BF1 is induced in remodelling vessels by chronic or transient VEGF stimulation•Infection of tumor vasculature orchestrated by PRD1-BF1 is critical for OV delivery
Arulanandam et al. show that VEGFR2 signaling in remodelling vessels induces the transcription repressor PRD1-BF1/Blimp1, which represses the expression of genes involved in type I interferon-mediated antiviral signaling, thus allowing oncolytic virus to infect tumor vasculatures to further spread within tumors.</description><subject>Animals</subject><subject>Cell Line</subject><subject>Cell Line, Tumor</subject><subject>Cells, Cultured</subject><subject>Gene Expression - drug effects</subject><subject>Gene Expression Profiling</subject><subject>Host-Pathogen Interactions</subject><subject>Human Umbilical Vein Endothelial Cells - drug effects</subject><subject>Human Umbilical Vein Endothelial Cells - metabolism</subject><subject>Human Umbilical Vein Endothelial Cells - virology</subject><subject>Humans</subject><subject>Mice, Inbred C57BL</subject><subject>Microscopy, Fluorescence</subject><subject>Neoplasms - blood supply</subject><subject>Neoplasms - therapy</subject><subject>Neoplasms - virology</subject><subject>Neovascularization, Pathologic - genetics</subject><subject>Neovascularization, Pathologic - metabolism</subject><subject>Neovascularization, Pathologic - virology</subject><subject>Oncolytic Viruses - physiology</subject><subject>Positive Regulatory Domain I-Binding Factor 1</subject><subject>Receptors, Vascular Endothelial Growth Factor - genetics</subject><subject>Receptors, Vascular Endothelial Growth Factor - metabolism</subject><subject>Repressor Proteins - genetics</subject><subject>Repressor Proteins - metabolism</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA Interference</subject><subject>Transcription Factors - genetics</subject><subject>Transcription Factors - metabolism</subject><subject>Transcriptional Activation - drug effects</subject><subject>Vaccinia virus</subject><subject>Vaccinia virus - physiology</subject><subject>Vascular Endothelial Growth Factor A - pharmacology</subject><issn>1535-6108</issn><issn>1878-3686</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUFv1DAQhSNERUvhFyAhH7kk9Ti24xw40LJbKrVqBWWvlmNPJK-SeLETRPn1eLuFI6ovtuT33mjeVxTvgFZAQZ5tK2txGCpGQVRUVpS2L4oTUI0qa6nky_wWtSglUHVcvE5pS7MLmvZVccwkA8YEPSnCZnW5Lm_QeTOjI1eTW-zsw0RCT-6-fobyfA1n54Mfd0BWv3YRU9r_fsMp-dn_xkTulzFEsjHJLoOZl4hkDuR2smF4mL0lGx-XlHN7fMx9Uxz1Zkj49uk-Lb6vV_cXX8rr28uri0_XpeVKtaVAx0WLnDc16w13AqyRHLqWKuWw7W3bcwldz4xyHc3r9DIf1knGhYTa1qfFh0PuLoYfC6ZZjz7t6zIThiVpaGgLUgA0z5HyWtSNFFlaH6Q2hpQi9noX_Wjigwaq91D0Vj9C0XsomkqdoWTX-6cBSzei--f5SyELPh4EmBv56THqZD1ONlOJuTbtgv_vgD-Zvp0L</recordid><startdate>20150810</startdate><enddate>20150810</enddate><creator>Arulanandam, Rozanne</creator><creator>Batenchuk, Cory</creator><creator>Angarita, Fernando A.</creator><creator>Ottolino-Perry, Kathryn</creator><creator>Cousineau, Sophie</creator><creator>Mottashed, Amelia</creator><creator>Burgess, Emma</creator><creator>Falls, Theresa J.</creator><creator>De Silva, Naomi</creator><creator>Tsang, Jovian</creator><creator>Howe, Grant A.</creator><creator>Bourgeois-Daigneault, Marie-Claude</creator><creator>Conrad, David P.</creator><creator>Daneshmand, Manijeh</creator><creator>Breitbach, Caroline J.</creator><creator>Kirn, David H.</creator><creator>Raptis, Leda</creator><creator>Sad, Subash</creator><creator>Atkins, Harold</creator><creator>Huh, Michael S.</creator><creator>Diallo, Jean-Simon</creator><creator>Lichty, Brian D.</creator><creator>Ilkow, Carolina S.</creator><creator>Le Boeuf, Fabrice</creator><creator>Addison, Christina L.</creator><creator>McCart, J. Andrea</creator><creator>Bell, John C.</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>20150810</creationdate><title>VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection</title><author>Arulanandam, Rozanne ; Batenchuk, Cory ; Angarita, Fernando A. ; Ottolino-Perry, Kathryn ; Cousineau, Sophie ; Mottashed, Amelia ; Burgess, Emma ; Falls, Theresa J. ; De Silva, Naomi ; Tsang, Jovian ; Howe, Grant A. ; Bourgeois-Daigneault, Marie-Claude ; Conrad, David P. ; Daneshmand, Manijeh ; Breitbach, Caroline J. ; Kirn, David H. ; Raptis, Leda ; Sad, Subash ; Atkins, Harold ; Huh, Michael S. ; Diallo, Jean-Simon ; Lichty, Brian D. ; Ilkow, Carolina S. ; Le Boeuf, Fabrice ; Addison, Christina L. ; McCart, J. Andrea ; Bell, John C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4889-5ed459e44732fa4d51ca641b9088de9fc9f461bf2a8db0262f66662b6245613c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Cell Line</topic><topic>Cell Line, Tumor</topic><topic>Cells, Cultured</topic><topic>Gene Expression - drug effects</topic><topic>Gene Expression Profiling</topic><topic>Host-Pathogen Interactions</topic><topic>Human Umbilical Vein Endothelial Cells - drug effects</topic><topic>Human Umbilical Vein Endothelial Cells - metabolism</topic><topic>Human Umbilical Vein Endothelial Cells - virology</topic><topic>Humans</topic><topic>Mice, Inbred C57BL</topic><topic>Microscopy, Fluorescence</topic><topic>Neoplasms - blood supply</topic><topic>Neoplasms - therapy</topic><topic>Neoplasms - virology</topic><topic>Neovascularization, Pathologic - genetics</topic><topic>Neovascularization, Pathologic - metabolism</topic><topic>Neovascularization, Pathologic - virology</topic><topic>Oncolytic Viruses - physiology</topic><topic>Positive Regulatory Domain I-Binding Factor 1</topic><topic>Receptors, Vascular Endothelial Growth Factor - genetics</topic><topic>Receptors, Vascular Endothelial Growth Factor - metabolism</topic><topic>Repressor Proteins - genetics</topic><topic>Repressor Proteins - metabolism</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA Interference</topic><topic>Transcription Factors - genetics</topic><topic>Transcription Factors - metabolism</topic><topic>Transcriptional Activation - drug effects</topic><topic>Vaccinia virus</topic><topic>Vaccinia virus - physiology</topic><topic>Vascular Endothelial Growth Factor A - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arulanandam, Rozanne</creatorcontrib><creatorcontrib>Batenchuk, Cory</creatorcontrib><creatorcontrib>Angarita, Fernando A.</creatorcontrib><creatorcontrib>Ottolino-Perry, Kathryn</creatorcontrib><creatorcontrib>Cousineau, Sophie</creatorcontrib><creatorcontrib>Mottashed, Amelia</creatorcontrib><creatorcontrib>Burgess, Emma</creatorcontrib><creatorcontrib>Falls, Theresa J.</creatorcontrib><creatorcontrib>De Silva, Naomi</creatorcontrib><creatorcontrib>Tsang, Jovian</creatorcontrib><creatorcontrib>Howe, Grant A.</creatorcontrib><creatorcontrib>Bourgeois-Daigneault, Marie-Claude</creatorcontrib><creatorcontrib>Conrad, David P.</creatorcontrib><creatorcontrib>Daneshmand, Manijeh</creatorcontrib><creatorcontrib>Breitbach, Caroline J.</creatorcontrib><creatorcontrib>Kirn, David H.</creatorcontrib><creatorcontrib>Raptis, Leda</creatorcontrib><creatorcontrib>Sad, Subash</creatorcontrib><creatorcontrib>Atkins, Harold</creatorcontrib><creatorcontrib>Huh, Michael S.</creatorcontrib><creatorcontrib>Diallo, Jean-Simon</creatorcontrib><creatorcontrib>Lichty, Brian D.</creatorcontrib><creatorcontrib>Ilkow, Carolina S.</creatorcontrib><creatorcontrib>Le Boeuf, Fabrice</creatorcontrib><creatorcontrib>Addison, Christina L.</creatorcontrib><creatorcontrib>McCart, J. Andrea</creatorcontrib><creatorcontrib>Bell, John C.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Cancer cell</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arulanandam, Rozanne</au><au>Batenchuk, Cory</au><au>Angarita, Fernando A.</au><au>Ottolino-Perry, Kathryn</au><au>Cousineau, Sophie</au><au>Mottashed, Amelia</au><au>Burgess, Emma</au><au>Falls, Theresa J.</au><au>De Silva, Naomi</au><au>Tsang, Jovian</au><au>Howe, Grant A.</au><au>Bourgeois-Daigneault, Marie-Claude</au><au>Conrad, David P.</au><au>Daneshmand, Manijeh</au><au>Breitbach, Caroline J.</au><au>Kirn, David H.</au><au>Raptis, Leda</au><au>Sad, Subash</au><au>Atkins, Harold</au><au>Huh, Michael S.</au><au>Diallo, Jean-Simon</au><au>Lichty, Brian D.</au><au>Ilkow, Carolina S.</au><au>Le Boeuf, Fabrice</au><au>Addison, Christina L.</au><au>McCart, J. Andrea</au><au>Bell, John C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection</atitle><jtitle>Cancer cell</jtitle><addtitle>Cancer Cell</addtitle><date>2015-08-10</date><risdate>2015</risdate><volume>28</volume><issue>2</issue><spage>210</spage><epage>224</epage><pages>210-224</pages><issn>1535-6108</issn><eissn>1878-3686</eissn><abstract>Oncolytic viruses designed to attack malignant cells can in addition infect and destroy tumor vascular endothelial cells. We show here that this expanded tropism of oncolytic vaccinia virus to the endothelial compartment is a consequence of VEGF-mediated suppression of the intrinsic antiviral response. VEGF/VEGFR2 signaling through Erk1/2 and Stat3 leads to upregulation, nuclear localization, and activation of the transcription repressor PRD1-BF1/Blimp1. PRD1-BF1 does not contribute to the mitogenic effects of VEGF, but directly represses genes involved in type I interferon (IFN)-mediated antiviral signaling. In vivo suppression of VEGF signaling diminishes PRD1-BF1/Blimp1 expression in tumor vasculature and inhibits intravenously administered oncolytic vaccinia delivery to and consequent spread within the tumor.
[Display omitted]
•VEGF/VEGFR2 signaling sensitizes endothelial cells to oncolytic virus infection•PRD1-BF1 mediates immune suppression in endothelial cells downstream of VEGF•PRD1-BF1 is induced in remodelling vessels by chronic or transient VEGF stimulation•Infection of tumor vasculature orchestrated by PRD1-BF1 is critical for OV delivery
Arulanandam et al. show that VEGFR2 signaling in remodelling vessels induces the transcription repressor PRD1-BF1/Blimp1, which represses the expression of genes involved in type I interferon-mediated antiviral signaling, thus allowing oncolytic virus to infect tumor vasculatures to further spread within tumors.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26212250</pmid><doi>10.1016/j.ccell.2015.06.009</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1535-6108 |
| ispartof | Cancer cell, 2015-08, Vol.28 (2), p.210-224 |
| issn | 1535-6108 1878-3686 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1709165117 |
| source | MEDLINE; Cell Press Free Archives; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Animals Cell Line Cell Line, Tumor Cells, Cultured Gene Expression - drug effects Gene Expression Profiling Host-Pathogen Interactions Human Umbilical Vein Endothelial Cells - drug effects Human Umbilical Vein Endothelial Cells - metabolism Human Umbilical Vein Endothelial Cells - virology Humans Mice, Inbred C57BL Microscopy, Fluorescence Neoplasms - blood supply Neoplasms - therapy Neoplasms - virology Neovascularization, Pathologic - genetics Neovascularization, Pathologic - metabolism Neovascularization, Pathologic - virology Oncolytic Viruses - physiology Positive Regulatory Domain I-Binding Factor 1 Receptors, Vascular Endothelial Growth Factor - genetics Receptors, Vascular Endothelial Growth Factor - metabolism Repressor Proteins - genetics Repressor Proteins - metabolism Reverse Transcriptase Polymerase Chain Reaction RNA Interference Transcription Factors - genetics Transcription Factors - metabolism Transcriptional Activation - drug effects Vaccinia virus Vaccinia virus - physiology Vascular Endothelial Growth Factor A - pharmacology |
| title | VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T06%3A15%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=VEGF-Mediated%20Induction%20of%20PRD1-BF1/Blimp1%20Expression%20Sensitizes%20Tumor%20Vasculature%20to%20Oncolytic%20Virus%20Infection&rft.jtitle=Cancer%20cell&rft.au=Arulanandam,%20Rozanne&rft.date=2015-08-10&rft.volume=28&rft.issue=2&rft.spage=210&rft.epage=224&rft.pages=210-224&rft.issn=1535-6108&rft.eissn=1878-3686&rft_id=info:doi/10.1016/j.ccell.2015.06.009&rft_dat=%3Cproquest_cross%3E1709165117%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1704353765&rft_id=info:pmid/26212250&rft_els_id=S1535610815002196&rfr_iscdi=true |